Total raised
$500K
Last: Series A 2014-11
Stage
Series A
Founded
2005
Headcount
5
HQ
Haifa
Sector
Health Tech & Life Sciences
About
AsMedic develops solutions to address the dynamic relationship between airway obstruction level and the correct drug dosage to treat asthma. AsMedics platform technology and concept are designed to ensure efficient and personalized drug therapy by delivering the optimal preplanned dosage into the lungs. Because the platform facilitates varied drug dosages, the patient can control the lungs deposition and bioavailability, improving therapy control and significantly decreasing the side effects of inhaled steroids.
Funding history · 1 round · $500K total
2014-11
Series A
$500K
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug DeliveryMedical DevicesMedical Treatment & Therapeutics
Technologies
Sensing
Target customers
Healthcare & Life SciencesHealthcarePatients
Business model
B2C
Highlights
1 PatentsVerified
Tags
non-invasiveinhalationasthmadrug-deliverymedical-devicesmedicationpersonalizationrespiratorychronic-patientshome-care